Purpose Renal cell carcinoma (RCC) is a very heterogeneous disease with widely varying
prognosis. An accurate knowledge of the individual risk of disease progression and mortality …

Purpose Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of
patients develop tumour recurrence. Prognostic scores are essential to guide individualised …

CONTEXT: The natural history of renal cell carcinoma (RCC) is highly unpredictable. Small
renal masses may be accompanied by metastatic disease. Conversely, patients with locally …

Objectives To review the most recent data on prognostic factors and describe the
characteristics and prognostic accuracy of the most important prognostic systems available …

The identification of prognostic factors in patients with renal cell carcinoma (RCC)
represents an area of increasing interest. The tumor, node, metastasis (TNM) staging system …

The most common type of cancer originating in the kidney is renal cell carcinoma (RCC). In
both localized and advanced RCC, a number of clinical, pathologic, and molecular factors …

PURPOSE:: Renal cell carcinoma (RCC) has traditionally been staged using a purely
anatomical staging system. Although current staging systems provide good prognostic …

Renal cell carcinoma (RCC) remains a major source of morbidity and mortality.
Approximately 40% of patients eventually die of cancer progression, making RCC the most …

PURPOSE: Determination of prognostic factors is essential for the management of renal cell
carcinoma. Stage, histological grade and type, and performance status are now well known …

Cancer of the kidney or renal pelvis will affect approximately 31,800 individuals in the United
States in 2002, with 11,600 estimated deaths [1]. These statistics seem to be rising annually …